Changes in the mucosal expression of interleukin 15 in Helicobacter pylori-associated gastritis
F Luzza1, T Parrello, G Monteleone
1Dipartimento di Medicina Sperimentale e Clinica, Università di Catanzaro Magna Graecia, Italy.
Abstract:
Transcripts for interleukin (IL) 15 were detected in the gastric mucosal samples of 5/5 (100%) patients with no evidence of Helicobacter pylori infection and in 4/14 (28%) H. pylori-infected patients (P< 0.05). Both IL-15 mRNA and IL-15 protein were detected in 1/6 (17%) patients who successfully underwent H. pylori eradication therapy, before treatment and in 5/6 (83%) cases after eradication. Even though a parallel significant (P < 0.03) improvement of gastritis score occurred after eradication, the severity of gastritis did not differ according to the mucosal IL-15 expression among H. pylori-infected patients, irrespective of the CagA serology. This study demonstrates, for the first time, that transcripts for IL-15 are expressed in the human gastric mucosa. Changes occurring during H. pylori colonisation and after eradication raise the hypothesis that H. pylori may down-regulate IL-15 expression in the gastric mucosa.
Insights
Interleukin-15 (IL-15) is expressed in the gastric mucosa. Helicobacter pylori infection may suppress IL-15 levels, which increase after successful eradication, suggesting a role for IL-15 in H. pylori-associated gastritis.
Area of Science:
- Immunology
- Gastroenterology
- Microbiology
Background:
- Interleukin-15 (IL-15) is a cytokine crucial for immune cell development and function.
- Gastric mucosal inflammation is a hallmark of Helicobacter pylori infection.
- The role of IL-15 in H. pylori-induced gastritis is not well understood.
Purpose of the Study:
- To investigate the expression of IL-15 in the human gastric mucosa.
- To determine the association between IL-15 levels and H. pylori infection status.
- To explore the changes in IL-15 expression following H. pylori eradication therapy.
Main Methods:
- Detection of IL-15 transcripts and protein in gastric mucosal biopsies.
- Comparison of IL-15 expression in H. pylori-positive and H. pylori-negative individuals.
- Assessment of IL-15 levels before and after successful H. pylori eradication.
Main Results:
- IL-15 transcripts were detected in 100% of H. pylori-negative patients and 28% of H. pylori-positive patients.
- IL-15 mRNA and protein were found in 17% of patients before eradication and 83% after successful eradication.
- Gastritis scores improved significantly after eradication, but IL-15 expression did not correlate with gastritis severity in H. pylori-infected patients.
Conclusions:
- This study provides the first evidence of IL-15 expression in the human gastric mucosa.
- H. pylori infection appears to down-regulate IL-15 expression in the gastric mucosa.
- IL-15 levels increase after successful H. pylori eradication, suggesting a potential role in gastritis resolution.
Related Concept Videos
Pathophysiology of Peptic Ulcer Disease: Injurious Factors
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds to M3...
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors
Gastritis-II: Pathophysiology
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
Peptic Ulcer
Gastritis II: Pathophysiology
Peptic Ulcer Disease II: Pathophysiology


